HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Kwality Pharmaceuticals gets registration for Bleomycin in Mexico
Aug-18-2025

Kwality Pharmaceutical has received registration for Bleomycin 15 IU in Mexico for sale and distribution. Bleomycin is a widely used anti-cancer medicine, effective in the treatment of Hodgkin’s lymphoma, testicular cancer, and certain squamous cell carcinomas. 

This approval further strengthens its expansion into highly regulated markets, reinforcing its commitment to delivering quality oncology products globally. The projected business potential is around $1 million in the first year, and supplies will commence before the end of Q2FY26.

Kwality Pharmaceuticals (formerly Kwality Pharmaceuticals) is a pharmaceutical formation company.

  RELATED NEWS >>